Alpha Teknova, Inc. (TKNO) income statement
TKNONasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/30124% above fair value
$7.65−0.12 (-1.54%)
Close on Nov 17, 2026Market cap $410.72MP/E –Yield –
Alpha Teknova, Inc. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- 34.6%
- Operating margin
- -36.2%
- Net margin
- -38.4%
- Return on equity, FY2025
- -22.8%
Financial strength
- Current ratio
- 4.49
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 87.4%
Valuation
- P/E ratio
- –
- Price to sales
- 9.40
- Price to book
- 6.56
- Dividend yield
- –
See a number that looks wrong?